NASDAQ: KZR
Kezar Life Sciences Inc Stock Ownership - Who owns Kezar Life Sciences?

Insider buying vs selling

Have Kezar Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pichi Luo ChiangSVP Corporate Controller2025-07-02264$4.28
$1.13kSell
Mark C. SchillerChief Operating Officer2025-07-02561$4.28
$2.40kSell

1 of 1

KZR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KZR insiders and whales buy or sell their stock.

KZR Shareholders

What type of owners hold Kezar Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Equal Talent Investments Ltd85.41%6,254,545$26.89MInsider
Morningside Venture Investments Ltd26.60%1,947,993$8.38MInsider
Cormorant Asset Management LP25.79%1,888,397$8.12MInsider
Omega Fund IV LP18.93%1,386,544$5.96MInsider
Onyx Therapeutics Inc15.31%1,121,384$4.82MInsider
Franklin M. Berger12.16%890,691$3.83MInsider
Tang Capital Management LLC9.83%720,000$3.10MInstitution
Suvretta Capital Management LLC9.79%716,759$3.08MInstitution
Bml Capital Management LLC8.67%635,183$2.73MInstitution
Bay City Capital LLC8.50%622,229$2.68MInsider

1 of 3

KZR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KZR22.01%77.99%Net Selling
IMA75.44%24.56%Net BuyingNet Buying
NRXS8.57%25.80%Net Selling
NRSN1.83%0.00%
TENX21.85%78.15%

Kezar Life Sciences Stock Ownership FAQ

Who owns Kezar Life Sciences?

Kezar Life Sciences (NASDAQ: KZR) is owned by 61.11% institutional shareholders, 216.48% Kezar Life Sciences insiders, and 0.00% retail investors. Equal Talent Investments Ltd is the largest individual Kezar Life Sciences shareholder, owning 6.25M shares representing 85.41% of the company. Equal Talent Investments Ltd's Kezar Life Sciences shares are currently valued at $26.08M.

If you're new to stock investing, here's how to buy Kezar Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.